Jupiter Neurosciences Statistics
Total Valuation
JUNS has a market cap or net worth of $13.36 million. The enterprise value is $14.66 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
JUNS has 36.28 million shares outstanding. The number of shares has increased by 20.31% in one year.
| Current Share Class | 36.28M |
| Shares Outstanding | 36.28M |
| Shares Change (YoY) | +20.31% |
| Shares Change (QoQ) | +12.16% |
| Owned by Insiders (%) | 49.48% |
| Owned by Institutions (%) | 4.48% |
| Float | 18.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 602.58 |
| Forward PS | 1.06 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 672.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.65
| Current Ratio | 0.65 |
| Quick Ratio | 0.51 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -134.94 |
Financial Efficiency
Return on equity (ROE) is -738.83% and return on invested capital (ROIC) is -141.37%.
| Return on Equity (ROE) | -738.83% |
| Return on Assets (ROA) | -94.64% |
| Return on Invested Capital (ROIC) | -141.37% |
| Return on Capital Employed (ROCE) | 486.32% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $4,359 |
| Profits Per Employee | -$1.73M |
| Employee Count | 5 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | -45.03% |
| 50-Day Moving Average | 0.43 |
| 200-Day Moving Average | 1.07 |
| Relative Strength Index (RSI) | 41.89 |
| Average Volume (20 Days) | 96,120 |
Short Selling Information
The latest short interest is 75,528, so 0.21% of the outstanding shares have been sold short.
| Short Interest | 75,528 |
| Short Previous Month | 126,917 |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.41% |
| Short Ratio (days to cover) | 0.61 |
Income Statement
In the last 12 months, JUNS had revenue of $21,796 and -$8.64 million in losses. Loss per share was -$0.25.
| Revenue | 21,796 |
| Gross Profit | -2.07M |
| Operating Income | -8.91M |
| Pretax Income | -8.64M |
| Net Income | -8.64M |
| EBITDA | n/a |
| EBIT | -8.91M |
| Loss Per Share | -$0.25 |
Full Income StatementBalance Sheet
The company has $3.79 million in cash and $5.32 million in debt, giving a net cash position of -$1.53 million or -$0.04 per share.
| Cash & Cash Equivalents | 3.79M |
| Total Debt | 5.32M |
| Net Cash | -1.53M |
| Net Cash Per Share | -$0.04 |
| Equity (Book Value) | -1.83M |
| Book Value Per Share | -0.05 |
| Working Capital | -2.57M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.41M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 5.43M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -40,873.19% |
| Pretax Margin | -39,662.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |